Knee Osteoarthritis
Overview
Knee osteoarthritis (OA) is a degenerative joint disease in which the cartilage that cushions the ends of the bones in the knee gradually breaks down. Over time, the joint surface can become rough, bone spurs may develop, and the joint may produce excess fluid, leading to pain and stiffness. OA is the most common form of arthritis and is a leading cause of disability worldwide.
- Who it affects: Primarily adults over 45, but it can occur in younger people after joint injury or in those with genetic predisposition.
- Prevalence: According to the CDC, about 14 million U.S. adults have knee OA, representing roughly 6% of the adult population. Globally, the WHO estimates that >300 million people live with symptomatic osteoarthritis.
- Impact: Knee OA is the single biggest contributor to years lived with disability (YLD) for musculoskeletal conditions, accounting for a 30‑40% reduction in quality‑of‑life scores among affected individuals.
Symptoms
The presentation of knee OA can vary from mild discomfort to severe, disabling pain. Common symptoms include:
- Joint pain: Typically worsens with activity (walking, climbing stairs) and improves with rest.
- Stiffness: Most noticeable after periods of inactivity (e.g., first thing in the morning or after sitting).
- Crepitus: A grinding or cracking sensation when moving the knee.
- Swelling: May be due to inflammatory synovitis or excess joint fluid.
- Reduced range of motion: Flexion and extension become limited, especially in advanced disease.
- Locking or catching: Small fragments of cartilage can get lodged, causing brief “locking” episodes.
- Muscle weakness: Disuse of the joint can lead to atrophy of the quadriceps and hamstrings.
- Pain at night: In later stages, pain may awaken the patient, especially if the joint is swollen.
Causes and Risk Factors
Knee OA results from a combination of mechanical, biological, and genetic factors.
Primary Causes
- Wear‑and‑tear of cartilage: The articular cartilage loses its ability to repair, becoming thin and fibrillated.
- Subchondral bone changes: Bone beneath the cartilage thickens and becomes sclerotic, contributing to pain.
- Inflammation: Low‑grade inflammation of the synovium releases cytokines that accelerate cartilage breakdown.
Risk Factors
- Age: Risk doubles each decade after age 45.
- Sex: Women develop knee OA more often than men, especially after menopause (likely hormonal influence).
- Obesity: Every extra pound adds about 4‑5 pounds of pressure on the knee; obesity increases risk 3‑4 fold (NIH, 2022).
- Previous joint injury: Meniscal tears, ligament ruptures, or fractures predispose the knee to early OA.
- Repeated stress: Occupations or sports involving heavy lifting, kneeling, or squatting (e.g., construction work, farming).
- Genetics: Family history raises risk; certain gene variants (e.g., COL2A1) affect cartilage integrity.
- Bone alignment: Varus (bow‑leg) or valgus (knock‑knee) malalignment concentrates load on one compartment of the knee.
- Metabolic diseases: Diabetes, hypertension, and dyslipidemia have been linked to higher OA incidence.
Diagnosis
Diagnosing knee OA involves a blend of clinical assessment, imaging, and, occasionally, laboratory tests to rule out other conditions.
Clinical Evaluation
- History: Duration of pain, aggravating/relieving factors, functional limitations.
- Physical exam: Observation of gait, assessment of swelling, range of motion, palpation for tenderness, and special tests (e.g., McMurray test for meniscal involvement).
Imaging Studies
- Plain radiographs: First‑line; look for joint space narrowing, osteophytes, subchondral sclerosis, and cysts. The Kellgren‑Lawrence grading system (0‑4) is commonly used.
- MRI: Provides detailed view of cartilage, menisci, ligaments, and synovium; reserved for atypical cases or when surgical planning is needed.
- Ultrasound: Useful for detecting effusions and assessing synovial inflammation in the office.
Laboratory Tests
Blood work is not diagnostic for OA but can help exclude other arthritides:
- Complete blood count (CBC) – rules out infection.
- Erythrocyte sedimentation rate (ESR) / C‑reactive protein (CRP) – elevated in inflammatory arthritis.
- Joint aspiration (arthrocentesis): If effusion is present, fluid analysis can differentiate OA (clear, low‑cell count) from gout, septic arthritis, or rheumatoid arthritis.
Treatment Options
Treatment is individualized and aims to relieve pain, preserve function, and delay joint replacement. A stepwise approach is recommended, starting with the least invasive measures.
1. Lifestyle and Physical Interventions
- Weight management: Losing 5–10% of body weight can reduce knee‑joint load by 40–50% and improve symptoms (Mayo Clinic, 2023).
- Exercise therapy:
- Low‑impact aerobic activities (walking, stationary cycling, swimming) 3‑5 times/week.
- Strength training focusing on quadriceps, hamstrings, and hip abductors.
- Flexibility and balance exercises (Tai Chi, yoga) to improve joint mechanics.
- Assistive devices: Knee braces, lateral-wedge insoles, or cane to reduce load on the affected compartment.
- Physical therapy: Tailored programs guided by a licensed therapist improve pain and function in >70% of participants (Cochrane Review, 2022).
2. Pharmacologic Management
| Medication Class | Typical Dose | Key Benefits / Risks |
|---|---|---|
| Acetaminophen (Paracetamol) | 500–1000 mg PO q6h (max 4 g/day) | Pain relief; low GI risk. Hepatotoxicity at high doses. |
| NSAIDs (ibuprofen, naproxen, diclofenac) | Ibuprofen 400–800 mg PO q6‑8h | Effective for inflammation & pain. GI ulcer, renal, CV risk—use lowest effective dose. |
| Topical NSAIDs (diclofenac gel) | Apply 2‑4 g to knee 3‑4 times/day | Fewer systemic side effects; modest pain reduction. |
| Intra‑articular corticosteroid injection | 40 mg methylprednisolone acetate | Rapid pain relief (1–2 weeks). Repeated use (>4/year) may damage cartilage. |
| Intra‑articular hyaluronic acid (viscosupplementation) | 1‑2 mL weekly for 3‑5 weeks | Improves lubrication; benefits vary. Generally safe. |
| Prescription duloxetine (SNRI) | 30 mg PO daily, titrate to 60 mg | Addresses chronic pain component; watch for nausea, insomnia. |
3. Procedural Interventions
- Platelet‑rich plasma (PRP) injections: Autologous growth factors may reduce pain; evidence is mixed.
- Arthroscopic debridement: Generally not recommended for isolated OA (AAOS guideline) but may be used if mechanical symptoms (e.g., loose bodies) coexist.
- Osteotomy: Realignment surgery (high tibial osteotomy) for younger, active patients with unicompartmental varus/valgus deformity.
- Total knee arthroplasty (TKA): Considered when pain interferes with daily life despite optimal non‑surgical therapy. Modern implants last 15–20 years on average.
4. Complementary Approaches
- Acupuncture, yoga, and mindfulness‑based stress reduction have modest analgesic effects in some trials.
- Supplements (glucosamine, chondroitin) – data are inconclusive; discuss with a healthcare provider before use.
Living with Knee Osteoarthritis
Effective daily management empowers patients to stay active and maintain independence.
- Joint protection: Use the “talk test” for activity intensity—if you can speak comfortably, you’re likely staying within a safe load.
- Heat & cold therapy: Warm packs before activity to loosen the joint; ice packs after activity to reduce swelling.
- Footwear: Wear supportive, low‑heeled shoes with good shock absorption; avoid high heels and worn‑out soles.
- Activity pacing: Break long tasks into shorter intervals with frequent rest breaks (e.g., 10 min walking → 2‑min rest).
- Medication adherence: Keep a medication log or use smartphone reminders to avoid missed doses.
- Regular follow‑up: Schedule appointments every 6‑12 months to monitor progression and adjust treatment.
- Support networks: Join local arthritis support groups or online communities for shared coping strategies.
Prevention
While age‑related degeneration cannot be fully prevented, several modifiable actions can lower risk.
- Maintain a healthy weight: Aim for a BMI < 25 kg/m²; even modest loss can delay onset.
- Engage in regular low‑impact exercise: At least 150 minutes of moderate aerobic activity per week.
- Strengthen the supporting musculature: Twice‑weekly resistance training for the quadriceps and hip stabilizers.
- Protect knees during high‑risk activities: Use proper technique, wear knee pads when kneeling, and avoid repetitive deep squats.
- Screen for malalignment: Early orthotic intervention for varus/valgus alignment reduces uneven wear.
- Manage comorbidities: Control diabetes, hypertension, and lipid levels to curb systemic inflammation.
Complications
If left unchecked, knee OA can lead to several downstream problems:
- Severe chronic pain: May cause depression, sleep disturbances, and reduced quality of life.
- Reduced mobility: Loss of ambulation independence increases fall risk.
- Joint deformity: Advanced OA can cause visible bow‑leg or knock‑knee alignment.
- Secondary muscle atrophy: Disuse leads to quadriceps weakness, further impairing joint stability.
- Cardiovascular disease: Physical inactivity linked to higher CV event rates; OA is an independent risk factor per CDC data.
- Need for joint replacement: Delayed treatment may necessitate earlier surgical intervention.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe knee pain after a fall or trauma.
- Inability to bear weight on the affected leg.
- Rapid swelling, redness, or warmth suggesting infection (septic arthritis).
- Fever (>38°C / 100.4°F) with knee pain and swelling.
- Sudden loss of movement or a “locking” sensation that does not resolve.
- Signs of deep‑vein thrombosis (pain, swelling, calf tenderness) accompanying knee pain.
These symptoms may indicate a fracture, joint infection, or other urgent conditions that require immediate medical attention.
References:
- Mayo Clinic. “Knee osteoarthritis.” https://www.mayoclinic.org. Accessed April 2026.
- Centers for Disease Control and Prevention. “Osteoarthritis Fact Sheet.” https://www.cdc.gov. 2023.
- National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Osteoarthritis.” https://www.niams.nih.gov. 2022.
- World Health Organization. “Joint health and osteoarthritis.” WHO Technical Report Series, 2021.
- Cochrane Database of Systematic Reviews. “Exercise therapy for knee osteoarthritis.” 2022; Issue 4.
- American Academy of Orthopaedic Surgeons. “Evidence-Based Clinical Practice Guideline for the Management of Knee Osteoarthritis.” 2020.